Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial.

Saved in:
Bibliographic Details
Title: Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial.
Authors: Mathieu, M. C., Goubar, A., Sigal, B., Bertheau, P., Guinebretière, J. M., André, F., Pierga, J. Y., Delaloge, S., Giacchetti, S., Brain, E., Marty, M.
Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p877-878. 2p.
Database: Academic Search Ultimate
Description
ISSN:00085472
DOI:10.1158/0008-5472.SABCS12-P3-06-04